Capital International Investors Has $60.31 Million Stake in Axon Enterprise, Inc. (NASDAQ:AXON)

Capital International Investors lowered its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 92.2% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 101,475 shares of the biotechnology company's stock after selling 1,207,000 shares during the quarter. Capital International Investors owned about 0.13% of Axon Enterprise worth $60,309,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. CANADA LIFE ASSURANCE Co increased its position in shares of Axon Enterprise by 15.7% in the fourth quarter. CANADA LIFE ASSURANCE Co now owns 69,648 shares of the biotechnology company's stock worth $41,345,000 after purchasing an additional 9,466 shares during the period. Canada Pension Plan Investment Board lifted its holdings in shares of Axon Enterprise by 8.0% during the 4th quarter. Canada Pension Plan Investment Board now owns 51,286 shares of the biotechnology company's stock worth $30,480,000 after acquiring an additional 3,799 shares during the period. First Commonwealth Financial Corp PA bought a new position in Axon Enterprise in the fourth quarter valued at approximately $273,000. NewEdge Advisors LLC raised its holdings in shares of Axon Enterprise by 13.4% during the 4th quarter. NewEdge Advisors LLC now owns 1,626 shares of the biotechnology company's stock worth $966,000 after buying an additional 192 shares in the last quarter. Finally, United Capital Financial Advisors LLC raised its stake in Axon Enterprise by 22.7% during the fourth quarter. United Capital Financial Advisors LLC now owns 1,185 shares of the biotechnology company's stock worth $704,000 after acquiring an additional 219 shares in the last quarter. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, CEO Patrick W. Smith sold 10,000 shares of the firm's stock in a transaction that occurred on Monday, April 21st. The shares were sold at an average price of $540.99, for a total transaction of $5,409,900.00. Following the completion of the sale, the chief executive officer now owns 3,063,982 shares of the company's stock, valued at $1,657,583,622.18. This trade represents a 0.33 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director Jeri Williams sold 307 shares of the business's stock in a transaction on Monday, March 17th. The shares were sold at an average price of $552.72, for a total transaction of $169,685.04. Following the transaction, the director now owns 1,627 shares in the company, valued at $899,275.44. The trade was a 15.87 % decrease in their position. The disclosure for this sale can be found here. 6.10% of the stock is currently owned by insiders.

Analysts Set New Price Targets

A number of brokerages have weighed in on AXON. Barclays restated a "hold" rating on shares of Axon Enterprise in a research report on Monday, March 10th. Craig Hallum lowered Axon Enterprise from a "buy" rating to a "cautious" rating in a research report on Monday, March 10th. TD Cowen started coverage on Axon Enterprise in a research report on Wednesday, January 8th. They issued a "buy" rating and a $700.00 target price for the company. JMP Securities reaffirmed an "outperform" rating on shares of Axon Enterprise in a research note on Tuesday, February 4th. Finally, Needham & Company LLC reiterated a "buy" rating and issued a $600.00 price objective on shares of Axon Enterprise in a report on Wednesday. One research analyst has rated the stock with a sell rating, two have issued a hold rating and nine have given a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $626.45.

Axon Enterprise Trading Up 1.8 %

AXON traded up $10.45 during trading on Friday, reaching $601.12. 244,650 shares of the stock traded hands, compared to its average volume of 772,743. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The stock's 50-day moving average is $547.64 and its 200 day moving average is $569.50. Axon Enterprise, Inc. has a 12 month low of $273.52 and a 12 month high of $715.99. The stock has a market capitalization of $46.80 billion, a PE ratio of 155.33, a P/E/G ratio of 5.17 and a beta of 1.13.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.